Search Results - "Mohan, Dipika R"
-
1
Targeting Oncogenic Wnt/β-Catenin Signaling in Adrenocortical Carcinoma Disrupts ECM Expression and Impairs Tumor Growth
Published in Cancers (10-07-2023)“…Adrenocortical carcinoma (ACC) is a rare but highly aggressive cancer with limited treatment options and poor survival for patients with advanced disease. An…”
Get full text
Journal Article -
2
SELAdb: A database of exonic variants in a Brazilian population referred to a quaternary medical center in São Paulo
Published in Clinics (São Paulo, Brazil) (01-01-2020)“…High-throughput sequencing of genomes, exomes, and disease-focused gene panels is becoming increasingly common for molecular diagnostics. However, identifying…”
Get full text
Journal Article -
3
Closing the loop on adrenal health, dysfunction, and disease
Published in Science translational medicine (21-06-2023)“…A wearable microdialysis device measures ultradian patterns of adrenal hormone secretion in humans at minute scale (Upton .)…”
Get more information
Journal Article -
4
Update on Biology and Genomics of Adrenocortical Carcinomas: Rationale for Emerging Therapies
Published in Endocrine reviews (01-12-2022)“…Abstract The adrenal glands are paired endocrine organs that produce steroid hormones and catecholamines required for life. Adrenocortical carcinoma (ACC) is a…”
Get full text
Journal Article -
5
Targeted Assessment of G0S2 Methylation Identifies a Rapidly Recurrent, Routinely Fatal Molecular Subtype of Adrenocortical Carcinoma
Published in Clinical cancer research (01-06-2019)“…Adrenocortical carcinoma (ACC) is a rare, aggressive malignancy with few therapies; however, patients with locoregional disease have variable outcomes. The…”
Get full text
Journal Article -
6
Therapeutic Targets for Adrenocortical Carcinoma in the Genomics Era
Published in Journal of the Endocrine Society (01-11-2018)“…Abstract Adrenocortical carcinoma (ACC) is a rare and often fatal cancer, affecting ~1 person per million per year worldwide. Approximately 75% of patients…”
Get full text
Journal Article -
7
Somatic Activating ESR1 Mutation in an Aggressive Prolactinoma
Published in The journal of clinical endocrinology and metabolism (06-09-2024)“…The genetic profile of prolactinomas remains poorly understood. Our objective is to identify somatic genetic alterations associated with prolactinomas and to…”
Get full text
Journal Article -
8
Impact of a cell cycle and an extracellular matrix remodeling transcriptional signature on tumor progression and correlation with EZH2 expression in meningioma
Published in Journal of neurosurgery (01-03-2023)“…The authors searched for genetic and transcriptional signatures associated with tumor progression and recurrence in their cohort of patients with meningiomas,…”
Get full text
Journal Article -
9
β-Catenin-Driven Differentiation Is a Tissue-Specific Epigenetic Vulnerability in Adrenal Cancer
Published in Cancer research (Chicago, Ill.) (05-07-2023)“…Adrenocortical carcinoma (ACC) is a rare cancer in which tissue-specific differentiation is paradoxically associated with dismal outcomes. The differentiated…”
Get full text
Journal Article -
10
Regulation of stem and progenitor cells in the adrenal cortex
Published in Current opinion in endocrine and metabolic research (01-10-2019)“…The adrenal cortex is an endocrine organ comprised of three histological zones, the outermost zona glomerulosa, the intermediate zona fasciculata, and the…”
Get full text
Journal Article -
11
New strategies for applying targeted therapies to adrenocortical carcinoma
Published in Current opinion in endocrine and metabolic research (01-10-2019)“…Adrenocortical carcinoma (ACC) is a rare, aggressive, and frequently deadly cancer. Up to 75% of all patients will eventually develop metastatic disease, and…”
Get full text
Journal Article -
12
Aberrant Epigenetic Patterning Defines an Aggressive Molecular Subtype of Adrenocortical Carcinoma and Exposes a Tissue-Specific Therapeutic Vulnerability
Published 01-01-2023“…The adrenal glands are endocrine organs that produce steroid hormones and catecholamines critical for life. Adrenocortical carcinoma (ACC) is a rare cancer of…”
Get full text
Dissertation -
13
U2AF1 mutations alter sequence specificity of pre-mRNA binding and splicing
Published in Leukemia (01-04-2015)“…We previously identified missense mutations in the U2AF1 splicing factor affecting codons S34 (S34F and S34Y) or Q157 (Q157R and Q157P) in 11% of the patients…”
Get full text
Journal Article -
14
OR20-04 Genetic Profiling Using A Gene Panel Identifies Pathogenic Variants And Copy Number Variations In Pituitary Adenomas
Published in Journal of the Endocrine Society (05-10-2023)“…Disclosure: T. Silva: None. D. Mohan: None. J. Mebarak: None. D. Meredith: None. W. Bi: Speaker; Self; Stryker. R. Carroll: None. U.B. Kaiser: None. A…”
Get full text
Journal Article -
15
7826 The Identification of an Activating ESR1 Mutation in an Aggressive Prolactinoma Enabled the Use of Personalized Treatment
Published in Journal of the Endocrine Society (05-10-2024)“…Disclosure: T. Paes: None. J.B. Mebarak: None. J. C. Magnotto: None. G. A. Stamatiades: None. Y. Kuang: None. C. Paweletz: None. E.R. Laws: None. R.S. Carroll:…”
Get full text
Journal Article -
16
Abstract 1501: Epigenetic dedifferentiation as a therapeutic strategy in adrenal cancer
Published in Cancer research (Chicago, Ill.) (04-04-2023)“…Adrenocortical carcinoma (ACC) is a rare cancer of the adrenal cortex without curative medical therapies. CIMP-high is an aggressive ACC molecular subtype…”
Get full text
Journal Article -
17
SAT-LB34 Repressive Epigenetic Programs Reinforce Steroidogenic Differentiation and Wnt/β-Catenin Signaling in Aggressive Adrenocortical Carcinoma
Published in Journal of the Endocrine Society (08-05-2020)“…Adrenocortical carcinoma (ACC) is a rare, aggressive cancer. Up to 75% of patients develop incurable metastatic disease, highlighting an urgent need for novel…”
Get full text
Journal Article